<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Guillain-Barr√© Syndrome - Interactive Algorithm</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #f5f7fa 0%, #e4e7f1 100%);
            color: #2c3e50;
            line-height: 1.6;
            min-height: 100vh;
        }

        .container {
            display: flex;
            max-width: 1400px;
            margin: 0 auto;
            min-height: 100vh;
        }

        .main-content {
            flex: 1;
            padding: 20px;
            margin-left: 280px;
        }

        .header {
            background: linear-gradient(135deg, #1a3a5f 0%, #2c3e50 100%);
            color: white;
            padding: 30px;
            border-radius: 12px;
            margin-bottom: 30px;
            box-shadow: 0 10px 30px rgba(0,0,0,0.1);
            position: relative;
            overflow: hidden;
        }

        .header::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: url('data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100"><circle cx="20" cy="20" r="2" fill="rgba(255,255,255,0.1)"/><circle cx="80" cy="40" r="1.5" fill="rgba(255,255,255,0.1)"/><circle cx="40" cy="80" r="1" fill="rgba(255,255,255,0.1)"/></svg>');
            opacity: 0.3;
        }

        .header h1 {
            font-size: 2.5em;
            margin-bottom: 10px;
            position: relative;
        }

        .header p {
            font-size: 1.1em;
            opacity: 0.9;
            position: relative;
        }

        .sidebar {
            position: fixed;
            left: 0;
            top: 0;
            width: 280px;
            height: 100vh;
            background: linear-gradient(180deg, #1a3a5f 0%, #2c3e50 100%);
            padding: 20px;
            overflow-y: auto;
            box-shadow: 5px 0 15px rgba(0,0,0,0.1);
            z-index: 100;
        }

        .sidebar h3 {
            color: white;
            margin-bottom: 20px;
            font-size: 1.3em;
            border-bottom: 2px solid rgba(255,255,255,0.2);
            padding-bottom: 10px;
        }

        .progress-item {
            display: flex;
            align-items: center;
            padding: 12px;
            margin-bottom: 10px;
            border-radius: 8px;
            cursor: pointer;
            transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
            color: rgba(255,255,255,0.8);
            background: rgba(255,255,255,0.05);
        }

        .progress-item:hover {
            background: rgba(255,255,255,0.15);
            transform: translateX(5px);
        }

        .progress-item.active {
            background: rgba(255,255,255,0.2);
            color: white;
            box-shadow: 0 4px 12px rgba(0,0,0,0.15);
        }

        .progress-icon {
            width: 36px;
            height: 36px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-right: 12px;
            font-size: 1.2em;
            transition: all 0.3s ease;
        }

        .progress-item.active .progress-icon {
            transform: scale(1.15);
            box-shadow: 0 0 0 3px rgba(255,255,255,0.3);
        }

        .step-card {
            background: white;
            border-radius: 12px;
            margin-bottom: 25px;
            box-shadow: 0 8px 25px rgba(0,0,0,0.08);
            overflow: hidden;
            transition: all 0.4s cubic-bezier(0.4, 0, 0.2, 1);
            border-left: 6px solid;
        }

        .step-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(0,0,0,0.12);
        }

        .step-card.assessment {
            border-left-color: #3498db;
        }

        .step-card.diagnosis {
            border-left-color: #9b59b6;
        }

        .step-card.treatment {
            border-left-color: #27ae60;
        }

        .step-card.followup {
            border-left-color: #e67e22;
        }

        .card-header {
            padding: 25px;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: space-between;
            background: linear-gradient(135deg, #f8f9fa 0%, #ffffff 100%);
            transition: all 0.3s ease;
        }

        .card-header:hover {
            background: linear-gradient(135deg, #ffffff 0%, #f8f9fa 100%);
        }

        .card-title-section {
            display: flex;
            align-items: center;
        }

        .card-icon {
            width: 50px;
            height: 50px;
            border-radius: 12px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.8em;
            margin-right: 20px;
            color: white;
            transition: all 0.3s ease;
        }

        .assessment .card-icon { background: #3498db; }
        .diagnosis .card-icon { background: #9b59b6; }
        .treatment .card-icon { background: #27ae60; }
        .followup .card-icon { background: #e67e22; }

        .step-card:hover .card-icon {
            transform: rotate(5deg) scale(1.1);
        }

        .card-title h2 {
            font-size: 1.8em;
            color: #2c3e50;
            margin-bottom: 5px;
        }

        .card-subtitle {
            color: #7f8c8d;
            font-size: 0.95em;
        }

        .expand-icon {
            font-size: 1.5em;
            color: #95a5a6;
            transition: all 0.3s ease;
        }

        .card-header:hover .expand-icon {
            color: #2c3e50;
            transform: scale(1.2);
        }

        .card-content {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s cubic-bezier(0.4, 0, 0.2, 1);
        }

        .card-content.expanded {
            max-height: 3000px;
        }

        .content-inner {
            padding: 0 25px 25px;
        }

        .subsection {
            margin-bottom: 25px;
            padding: 20px;
            background: #f8f9fa;
            border-radius: 8px;
            border-left: 4px solid;
        }

        .assessment .subsection { border-left-color: #3498db; }
        .diagnosis .subsection { border-left-color: #9b59b6; }
        .treatment .subsection { border-left-color: #27ae60; }
        .followup .subsection { border-left-color: #e67e22; }

        .subsection h3 {
            font-size: 1.3em;
            margin-bottom: 15px;
            color: #2c3e50;
            display: flex;
            align-items: center;
        }

        .subsection h3::before {
            content: '‚Ä¢';
            margin-right: 10px;
            font-size: 1.5em;
            color: inherit;
        }

        .badge {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 20px;
            font-size: 0.85em;
            font-weight: 600;
            margin-left: 10px;
            text-transform: uppercase;
            letter-spacing: 0.5px;
        }

        .badge.urgent {
            background: #e74c3c;
            color: white;
        }

        .badge.caution {
            background: #f39c12;
            color: white;
        }

        .badge.stable {
            background: #27ae60;
            color: white;
        }

        .badge.info {
            background: #3498db;
            color: white;
        }

        .key-points {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 15px;
            margin-top: 15px;
        }

        .point-card {
            background: white;
            padding: 15px;
            border-radius: 6px;
            border-left: 3px solid;
            transition: all 0.3s ease;
        }

        .point-card:hover {
            transform: translateY(-3px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }

        .assessment .point-card { border-left-color: #3498db; }
        .diagnosis .point-card { border-left-color: #9b59b6; }
        .treatment .point-card { border-left-color: #27ae60; }
        .followup .point-card { border-left-color: #e67e22; }

        .test-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 15px;
            margin-top: 15px;
        }

        .test-card {
            background: white;
            padding: 15px;
            border-radius: 6px;
            border: 1px solid #e0e0e0;
            transition: all 0.3s ease;
        }

        .test-card:hover {
            border-color: #3498db;
            box-shadow: 0 5px 15px rgba(52, 152, 219, 0.1);
        }

        .test-card h4 {
            color: #2c3e50;
            margin-bottom: 8px;
            font-size: 1.1em;
        }

        .test-card p {
            font-size: 0.9em;
            color: #7f8c8d;
        }

        .algorithm-path {
            background: linear-gradient(135deg, #e8f4f8 0%, #f0f7f4 100%);
            padding: 20px;
            border-radius: 8px;
            margin: 15px 0;
            border: 2px dashed #3498db;
        }

        .algorithm-path h4 {
            color: #2c3e50;
            margin-bottom: 15px;
            display: flex;
            align-items: center;
        }

        .algorithm-path h4::before {
            content: '‚Üí';
            margin-right: 10px;
            font-size: 1.5em;
            color: #3498db;
        }

        .treatment-option {
            background: white;
            margin: 10px 0;
            padding: 15px;
            border-radius: 6px;
            border-left: 4px solid #27ae60;
            transition: all 0.3s ease;
        }

        .treatment-option:hover {
            transform: translateX(5px);
            box-shadow: 0 5px 15px rgba(0,0,0,0.1);
        }

        .treatment-option h4 {
            color: #27ae60;
            margin-bottom: 8px;
        }

        .complication-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin-top: 15px;
        }

        .complication-card {
            background: white;
            border-radius: 8px;
            overflow: hidden;
            box-shadow: 0 4px 12px rgba(0,0,0,0.08);
            transition: all 0.3s ease;
        }

        .complication-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 25px rgba(0,0,0,0.12);
        }

        .complication-header {
            padding: 15px;
            color: white;
            font-weight: 600;
        }

        .complication-body {
            padding: 15px;
        }

        .complication-body p {
            font-size: 0.9em;
            color: #7f8c8d;
            margin-bottom: 10px;
        }

        .likelihood-bar {
            display: flex;
            align-items: center;
            margin-top: 10px;
        }

        .likelihood-label {
            font-size: 0.8em;
            color: #7f8c8d;
            margin-right: 10px;
            min-width: 60px;
        }

        .likelihood-progress {
            flex: 1;
            height: 6px;
            background: #ecf0f1;
            border-radius: 3px;
            overflow: hidden;
        }

        .likelihood-fill {
            height: 100%;
            transition: width 0.5s ease;
        }

        .likelihood-fill.high { background: #e74c3c; }
        .likelihood-fill.medium { background: #f39c12; }
        .likelihood-fill.low { background: #27ae60; }

        .criteria-box {
            background: #f8f9fa;
            padding: 20px;
            border-radius: 8px;
            margin: 15px 0;
            border: 1px solid #e0e0e0;
        }

        .criteria-list {
            list-style: none;
            padding-left: 0;
        }

        .criteria-list li {
            padding: 8px 0;
            padding-left: 30px;
            position: relative;
        }

        .criteria-list li::before {
            content: '‚úì';
            position: absolute;
            left: 0;
            color: #27ae60;
            font-weight: bold;
            font-size: 1.2em;
        }

        .criteria-list li.negative::before {
            content: '‚úó';
            color: #e74c3c;
        }

        .highlight-box {
            background: linear-gradient(135deg, #fff3cd 0%, #ffeaa7 100%);
            border: 1px solid #f39c12;
            border-radius: 8px;
            padding: 15px;
            margin: 15px 0;
        }

        .warning-box {
            background: linear-gradient(135deg, #f8d7da 0%, #fab1a0 100%);
            border: 1px solid #e74c3c;
            border-radius: 8px;
            padding: 15px;
            margin: 15px 0;
        }

        .warning-box h4 {
            color: #c0392b;
            margin-bottom: 10px;
        }

        .highlight-box h4 {
            color: #d35400;
            margin-bottom: 10px;
        }

        @media (max-width: 768px) {
            .sidebar {
                width: 250px;
            }
            .main-content {
                margin-left: 250px;
            }
            .header h1 {
                font-size: 2em;
            }
            .key-points {
                grid-template-columns: 1fr;
            }
            .test-grid {
                grid-template-columns: 1fr;
            }
            .complication-grid {
                grid-template-columns: 1fr;
            }
        }

        @media (max-width: 576px) {
            .sidebar {
                width: 200px;
            }
            .main-content {
                margin-left: 200px;
                padding: 15px;
            }
            .card-header {
                padding: 20px;
            }
            .card-icon {
                width: 40px;
                height: 40px;
                font-size: 1.5em;
                margin-right: 15px;
            }
            .card-title h2 {
                font-size: 1.5em;
            }
        }

        .fade-in {
            animation: fadeIn 0.6s ease-in;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        .pulse {
            animation: pulse 2s infinite;
        }

        @keyframes pulse {
            0% { box-shadow: 0 0 0 0 rgba(255,255,255,0.4); }
            70% { box-shadow: 0 0 0 10px rgba(255,255,255,0); }
            100% { box-shadow: 0 0 0 0 rgba(255,255,255,0); }
        }

        .scroll-to-top {
            position: fixed;
            bottom: 30px;
            right: 30px;
            width: 50px;
            height: 50px;
            background: #3498db;
            color: white;
            border: none;
            border-radius: 50%;
            cursor: pointer;
            display: none;
            align-items: center;
            justify-content: center;
            font-size: 1.5em;
            box-shadow: 0 4px 15px rgba(0,0,0,0.2);
            transition: all 0.3s ease;
            z-index: 99;
        }

        .scroll-to-top:hover {
            background: #2980b9;
            transform: translateY(-3px);
        }

        .scroll-to-top.show {
            display: flex;
        }
    </style>
</head>
<body>
    <div class="container">
        <!-- Sticky Progress Sidebar -->
        <aside class="sidebar">
            <h3>Algorithm Progress</h3>
            <div class="progress-item active" data-step="assessment">
                <div class="progress-icon" style="background: #3498db;">üìã</div>
                <span>Assessment</span>
            </div>
            <div class="progress-item" data-step="diagnosis">
                <div class="progress-icon" style="background: #9b59b6;">üîç</div>
                <span>Diagnosis</span>
            </div>
            <div class="progress-item" data-step="treatment">
                <div class="progress-icon" style="background: #27ae60;">üíä</div>
                <span>Treatment</span>
            </div>
            <div class="progress-item" data-step="followup">
                <div class="progress-icon" style="background: #e67e22;">üìà</div>
                <span>Follow-up</span>
            </div>
        </aside>

        <!-- Main Content -->
        <main class="main-content">
            <div class="header fade-in">
                <h1>Guillain-Barr√© Syndrome</h1>
                <p>Interactive Clinical Algorithm | BMJ Best Practice Guidelines</p>
            </div>

            <!-- Assessment Card -->
            <div class="step-card assessment fade-in" id="assessment">
                <div class="card-header" onclick="toggleCard('assessment')">
                    <div class="card-title-section">
                        <div class="card-icon">üìã</div>
                        <div class="card-title">
                            <h2>Assessment</h2>
                            <p class="card-subtitle">Initial evaluation and risk stratification</p>
                        </div>
                    </div>
                    <div class="expand-icon" id="icon-assessment">‚ñº</div>
                </div>
                <div class="card-content" id="content-assessment">
                    <div class="content-inner">
                        <div class="subsection">
                            <h3>Key Clinical Features <span class="badge urgent">Red Flag</span></h3>
                            <div class="key-points">
                                <div class="point-card">
                                    <strong>Progressive Weakness</strong>
                                    <p>Ascending, symmetrical muscle weakness affecting lower limbs before upper limbs, proximal before distal</p>
                                </div>
                                <div class="point-card">
                                    <strong>Areflexia/Hyporeflexia</strong>
                                    <p>Absent or reduced deep tendon reflexes, typically in weakest limbs</p>
                                </div>
                                <div class="point-card">
                                    <strong>Sensory Symptoms</strong>
                                    <p>Paraesthesias in hands and feet, often preceding weakness. Usually mild objective sensory loss</p>
                                </div>
                                <div class="point-card">
                                    <strong>Autonomic Dysfunction</strong>
                                    <p>Sinus tachycardia, labile BP, postural hypotension, urinary retention, ileus</p>
                                </div>
                                <div class="point-card">
                                    <strong>Cranial Nerve Involvement</strong>
                                    <p>Facial weakness (50-60%), bulbar dysfunction, extraocular muscle weakness (15%)</p>
                                </div>
                                <div class="point-card">
                                    <strong>Pain</strong>
                                    <p>Back and leg pain common, especially prominent in children</p>
                                </div>
                            </div>

                            <div class="warning-box">
                                <h4>‚ö†Ô∏è Respiratory Warning Signs</h4>
                                <p>20-30% of patients develop respiratory muscle weakness requiring mechanical ventilation. Monitor for:</p>
                                <ul style="margin-top: 10px; padding-left: 20px;">
                                    <li>Bulbar dysfunction (odds ratio 17.5 for intubation)</li>
                                    <li>Rapid disease progression</li>
                                    <li>Bilateral facial weakness</li>
                                    <li>Dysautonomia</li>
                                    <li>Inability to lift head or cough</li>
                                </ul>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Risk Factors & Triggers</h3>
                            <div class="key-points">
                                <div class="point-card">
                                    <strong>Preceding Infection</strong>
                                    <p>Two-thirds have viral (CMV, EBV, hepatitis E) or bacterial (C. jejuni) infection 1-3 weeks prior</p>
                                </div>
                                <div class="point-card">
                                    <strong>Campylobacter jejuni</strong>
                                    <p>Precedes 60-70% of AMAN/AMSAN cases, 30% of AIDP. 100-fold increased risk in 2 months post-infection</p>
                                </div>
                                <div class="point-card">
                                    <strong>Viral Infections</strong>
                                    <p>Zika virus (1.23% develop GBS), COVID-19, dengue, chikungunya, Japanese encephalitis</p>
                                </div>
                                <div class="point-card">
                                    <strong>Demographics</strong>
                                    <p>Slight male predominance (1.78:1), incidence increases with age (mean 40 years)</p>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Respiratory Assessment <span class="badge urgent">Critical</span></h3>
                            <div class="algorithm-path">
                                <h4>20/30/40 Rule for Intubation</h4>
                                <p>Consider ICU admission and elective intubation if ANY of the following are present:</p>
                                <ul style="margin-top: 10px; padding-left: 20px;">
                                    <li>Vital capacity < 20 mL/kg (odds ratio 15.0)</li>
                                    <li>Maximal inspiratory pressure worse than -30 cmH‚ÇÇO</li>
                                    <li>Maximal expiratory pressure < 40 cmH‚ÇÇO</li>
                                    <li>Reduction of 30% or more in any parameter from baseline</li>
                                </ul>
                            </div>
                            <p><strong>Monitor:</strong> Bedside spirometry every 6 hours initially. Do NOT rely on pulse oximetry or arterial blood gases alone (late signs).</p>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Diagnosis Card -->
            <div class="step-card diagnosis fade-in" id="diagnosis">
                <div class="card-header" onclick="toggleCard('diagnosis')">
                    <div class="card-title-section">
                        <div class="card-icon">üîç</div>
                        <div class="card-title">
                            <h2>Diagnosis</h2>
                            <p class="card-subtitle">Diagnostic criteria and investigations</p>
                        </div>
                    </div>
                    <div class="expand-icon" id="icon-diagnosis">‚ñº</div>
                </div>
                <div class="card-content" id="content-diagnosis">
                    <div class="content-inner">
                        <div class="subsection">
                            <h3>Diagnostic Criteria</h3>
                            <div class="criteria-box">
                                <h4>Required Features</h4>
                                <ul class="criteria-list">
                                    <li>Progressive weakness in both arms and legs</li>
                                    <li>Areflexia or hyporeflexia</li>
                                </ul>
                            </div>
                            <div class="criteria-box">
                                <h4>Supportive Features</h4>
                                <ul class="criteria-list">
                                    <li>Progression over days to 4 weeks</li>
                                    <li>Relative symmetry</li>
                                    <li>Mild sensory signs or symptoms</li>
                                    <li>Cranial nerve involvement, especially bilateral facial weakness</li>
                                    <li>Recovery beginning 2-4 weeks after progression ceases</li>
                                    <li>Albuminocytological dissociation in CSF</li>
                                    <li>Electrophysiological evidence of demyelination</li>
                                </ul>
                            </div>
                            <div class="warning-box">
                                <h4>Features That Rule Out Diagnosis</h4>
                                <ul class="criteria-list">
                                    <li class="negative">Recent diphtheria infection</li>
                                    <li class="negative">Abnormal porphyrin metabolism</li>
                                    <li class="negative">Hexacarbon abuse or lead intoxication</li>
                                    <li class="negative">Poliomyelitis, botulism, hysterical paralysis</li>
                                </ul>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>First-Line Investigations <span class="badge urgent">Order Immediately</span></h3>
                            <div class="test-grid">
                                <div class="test-card">
                                    <h4>Nerve Conduction Studies</h4>
                                    <p>Prolonged distal & F-wave latencies, reduced conduction velocities, H reflex prolonged/absent. Test 3 sensory & 3 motor nerves bilaterally.</p>
                                </div>
                                <div class="test-card">
                                    <h4>Lumbar Puncture</h4>
                                    <p>CSF: Elevated protein with normal cell count (&lt;5 cells/mm¬≥). May be normal in first 2 weeks. 15% have mild pleocytosis (5-50 cells/mm¬≥).</p>
                                </div>
                                <div class="test-card">
                                    <h4>S pirometry</h4>
                                    <p>Bedside spirometry every 6 hours initially. Monitor vital capacity, maximal inspiratory/expiratory pressures.</p>
                                </div>
                                <div class="test-card">
                                    <h4>Liver Function Tests</h4>
                                    <p>Aminotransferases may be elevated (up to 500 U/L) in first few days, normalizing by 1-2 weeks. Correlates with disease severity.</p>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Additional Investigations</h3>
                            <div class="test-grid">
                                <div class="test-card">
                                    <h4>Anti-ganglioside Antibodies</h4>
                                    <p>Limited diagnostic value. Consider for variant syndromes: anti-GQ1b (MFS, 90% positive), anti-GT1a (pharyngeal-cervical-brachial).</p>
                                </div>
                                <div class="test-card">
                                    <h4>Serology & Stool Culture</h4>
                                    <p>C. jejuni, CMV, EBV, Mycoplasma for epidemiological purposes. C. jejuni positive serology associated with worse prognosis.</p>
                                </div>
                                <div class="test-card">
                                    <h4>Spinal MRI</h4>
                                    <p>Consider if diagnosis unclear. May show nerve root enhancement (83% sensitive). Exclude spinal cord pathology (abscess, myelitis).</p>
                                </div>
                                <div class="test-card">
                                    <h4>HIV Testing</h4>
                                    <p>Indicated if high risk or CSF pleocytosis &gt;10 cells/mm¬≥.</p>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Differential Diagnosis</h3>
                            <div class="key-points">
                                <div class="point-card">
                                    <strong>Transverse Myelitis</strong>
                                    <p>Sensory level, early bowel/bladder dysfunction, hyperreflexia, MRI focal demyelination</p>
                                </div>
                                <div class="point-card">
                                    <strong>Myasthenia Gravis</strong>
                                    <p>Fluctuating weakness, preserved reflexes, no sensory loss, positive edrophonium test</p>
                                </div>
                                <div class="point-card">
                                    <strong>Botulism</strong>
                                    <p>Descending paralysis, fixed dilated pupils, constipation, EMG shows incremental response</p>
                                </div>
                                <div class="point-card">
                                    <strong>Polymyositis</strong>
                                    <p>Muscle pain/tenderness, preserved reflexes, no dysautonomia, elevated CK</p>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Treatment Card -->
            <div class="step-card treatment fade-in" id="treatment">
                <div class="card-header" onclick="toggleCard('treatment')">
                    <div class="card-title-section">
                        <div class="card-icon">üíä</div>
                        <div class="card-title">
                            <h2>Treatment</h2>
                            <p class="card-subtitle">Disease-modifying & supportive therapy</p>
                        </div>
                    </div>
                    <div class="expand-icon" id="icon-treatment">‚ñº</div>
                </div>
                <div class="card-content" id="content-treatment">
                    <div class="content-inner">
                        <div class="subsection">
                            <h3>Principles of Treatment</h3>
                            <p>Multidisciplinary approach combining supportive therapy and disease-modifying therapy with either IVIG or plasma exchange. <strong>Start treatment within 2 weeks</strong> of symptom onset for optimal outcomes.</p>
                        </div>

                        <div class="subsection">
                            <h3>Disease-Modifying Therapy <span class="badge urgent">Time Critical</span></h3>
                            
                            <div class="algorithm-path">
                                <h4>First-Line Treatment Options</h4>
                                <p><strong>IVIG and plasma exchange are equally efficacious.</strong> Choice depends on availability, contraindications, and institutional preference.</p>
                            </div>

                            <div class="treatment-option">
                                <h4>Intravenous Immunoglobulin (IVIG) <span class="badge info">Preferred</span></h4>
                                <p><strong>Indication:</strong> Ambulatory patients ‚â§2 weeks from onset, or non-ambulatory ‚â§4 weeks</p>
                                <p><strong>Dose:</strong> 400 mg/kg/day for 5 days (total 2 g/kg)</p>
                                <p><strong>Advantages:</strong> Peripheral IV access, fewer complications, easier administration</p>
                                <p><strong>Contraindications:</strong> IgA deficiency (anaphylaxis risk), severe renal failure</p>
                            </div>

                            <div class="treatment-option">
                                <h4>Plasma Exchange (Plasmapheresis)</h4>
                                <p><strong>Indication:</strong> Non-ambulatory patients within 4 weeks of onset</p>
                                <p><strong>Regimen:</strong> 50 mL/kg every other day for 7-14 days (total 5 exchanges)</p>
                                <p><strong>Advantages:</strong> Preferred in IgA deficiency or renal failure</p>
                                <p><strong>Disadvantages:</strong> Requires central venous access, more complications (infection, hypotension)</p>
                            </div>

                            <div class="warning-box">
                                <h4>‚ö†Ô∏è Important Notes</h4>
                                <ul style="padding-left: 20px;">
                                    <li><strong>Combination therapy</strong> (plasma exchange + IVIG) is NOT recommended</li>
                                    <li><strong>Second IVIG course</strong> NOT recommended even for poor prognosis (increased adverse events)</li>
                                    <li><strong>Corticosteroids</strong> do NOT significantly improve outcomes and may delay recovery</li>
                                </ul>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Supportive Therapy <span class="badge caution">Critical Care</span></h3>
                            
                            <div class="key-points">
                                <div class="point-card">
                                    <strong>Respiratory Management</strong>
                                    <p>ICU monitoring for at-risk patients. Early intubation for bulbar dysfunction or VC &lt;20 mL/kg. Monitor with serial PFTs.</p>
                                </div>
                                <div class="point-card">
                                    <strong>Cardiovascular Monitoring</strong>
                                    <p>Continuous telemetry for dysautonomia. Treat hypertension with short-acting agents (labetalol, esmolol).</p>
                                </div>
                                <div class="point-card">
                                    <strong>DVT Prophylaxis</strong>
                                    <p>Anticoagulation (LMWH or DOAC) + compression stockings for non-ambulatory patients.</p>
                                </div>
                                <div class="point-card">
                                    <strong>Pain Management</strong>
                                    <p>Gabapentin, carbamazepine, amitriptyline for neuropathic pain. Use opioids cautiously (worsen autonomic dysfunction).</p>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Rehabilitation</h3>
                            <p>Start <strong>gentle strengthening exercises</strong> in acute phase:</p>
                            <ul style="margin: 10px 0; padding-left: 20px;">
                                <li>Isometric, isotonic, isokinetic exercises</li>
                                <li>Manual resistive and progressive resistive exercises</li>
                                <li>Proper limb positioning and posture</li>
                                <li>Orthotics and nutrition support</li>
                                <li>Multidisciplinary approach improves outcomes</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Follow-up Card -->
            <div class="step-card followup fade-in" id="followup">
                <div class="card-header" onclick="toggleCard('followup')">
                    <div class="card-title-section">
                        <div class="card-icon">üìà</div>
                        <div class="card-title">
                            <h2>Follow-up</h2>
                            <p class="card-subtitle">Monitoring, complications & prognosis</p>
                        </div>
                    </div>
                    <div class="expand-icon" id="icon-followup">‚ñº</div>
                </div>
                <div class="card-content" id="content-followup">
                    <div class="content-inner">
                        <div class="subsection">
                            <h3>Disease Course Monitoring</h3>
                            <div class="key-points">
                                <div class="point-card">
                                    <strong>Progressive Phase</strong>
                                    <p>Symptoms worsen for up to 2 weeks (80% reach nadir by 2 weeks, 97% by 4 weeks)</p>
                                </div>
                                <div class="point-card">
                                    <strong>Plateau Phase</strong>
                                    <p>Persistent, unchanging symptoms lasting 2-4 weeks</p>
                                </div>
                                <div class="point-card">
                                    <strong>Recovery Phase</strong>
                                    <p>Recovery begins 2-4 weeks after progression ceases. Most regain independent walking by 6 months</p>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Complications <span class="badge caution">Monitor Closely</span></h3>
                            <div class="complication-grid">
                                <div class="complication-card">
                                    <div class="complication-header" style="background: #e74c3c;">
                                        Respiratory Failure
                                    </div>
                                    <div class="complication-body">
                                        <p>20-30% require mechanical ventilation. Monitor with serial PFTs. Mean ventilation duration: 15-43 days.</p>
                                        <div class="likelihood-bar">
                                            <span class="likelihood-label">Likelihood:</span>
                                            <div class="likelihood-progress">
                                                <div class="likelihood-fill medium" style="width: 60%;"></div>
                                            </div>
                                            <span class="likelihood-label">Medium</span>
                                        </div>
                                    </div>
                                </div>
                                <div class="complication-card">
                                    <div class="complication-header" style="background: #f39c12;">
                                        Autonomic Dysfunction
                                    </div>
                                    <div class="complication-body">
                                        <p>Cardiac arrhythmias, labile BP, ileus, urinary retention. Monitor with telemetry and fluid balance.</p>
                                        <div class="likelihood-bar">
                                            <span class="likelihood-label">Likelihood:</span>
                                            <div class="likelihood-progress">
                                                <div class="likelihood-fill medium" style="width: 60%;"></div>
                                            </div>
                                            <span class="likelihood-label">Medium</span>
                                        </div>
                                    </div>
                                </div>
                                <div class="complication-card">
                                    <div class="complication-header" style="background: #e67e22;">
                                        Deep Vein Thrombosis
                                    </div>
                                    <div class="complication-body">
                                        <p>Risk from immobility and IVIG-induced hypercoagulability. Use prophylactic anticoagulation.</p>
                                        <div class="likelihood-bar">
                                            <span class="likelihood-label">Likelihood:</span>
                                            <div class="likelihood-progress">
                                                <div class="likelihood-fill medium" style="width: 50%;"></div>
                                            </div>
                                            <span class="likelihood-label">Medium</span>
                                        </div>
                                    </div>
                                </div>
                                <div class="complication-card">
                                    <div class="complication-header" style="background: #27ae60;">
                                        Fatigue
                                    </div>
                                    <div class="complication-body">
                                        <p>Common long-term sequela (high likelihood). Supervised exercise programs recommended.</p>
                                        <div class="likelihood-bar">
                                            <span class="likelihood-label">Likelihood:</span>
                                            <div class="likelihood-progress">
                                                <div class="likelihood-fill high" style="width: 85%;"></div>
                                            </div>
                                            <span class="likelihood-label">High</span>
                                        </div>
                                    </div>
                                </div>
                                <div class="complication-card">
                                    <div class="complication-header" style="background: #9b59b6;">
                                        Psychological Problems
                                    </div>
                                    <div class="complication-body">
                                        <p>Depression, anxiety, PTSD. Early recognition and referral to psychologist/psychiatrist important.</p>
                                        <div class="likelihood-bar">
                                            <span class="likelihood-label">Likelihood:</span>
                                            <div class="likelihood-progress">
                                                <div class="likelihood-fill medium" style="width: 50%;"></div>
                                            </div>
                                            <span class="likelihood-label">Medium</span>
                                        </div>
                                    </div>
                                </div>
                                <div class="complication-card">
                                    <div class="complication-header" style="background: #34495e;">
                                        Neuropathic Pain
                                    </div>
                                    <div class="complication-body">
                                        <p>Chronic pain affects many patients. Manage with gabapentin, carbamazepine, amitriptyline.</p>
                                        <div class="likelihood-bar">
                                            <span class="likelihood-label">Likelihood:</span>
                                            <div class="likelihood-progress">
                                                <div class="likelihood-fill high" style="width: 70%;"></div>
                                            </div>
                                            <span class="likelihood-label">High</span>
                                        </div>
                                    </div>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Prognosis</h3>
                            <div class="highlight-box">
                                <h4>Overall Prognosis: GOOD</h4>
                                <ul style="padding-left: 20px;">
                                    <li><strong>85%</strong> make good functional recovery</li>
                                    <li><strong>80%</strong> walk independently by 6 months</li>
                                    <li>Miller-Fisher syndrome: most recover completely within 6 months without treatment</li>
                                    <li>Recovery may be prolonged in severe disease but most regain independent walking</li>
                                </ul>
                            </div>
                            <div class="key-points">
                                <div class="point-card">
                                    <strong>Poor Prognostic Factors</strong>
                                    <ul style="padding-left: 20px; margin-top: 8px;">
                                        <li>More severe weakness at nadir</li>
                                        <li>Rapid onset of symptoms</li>
                                        <li>Older age (&gt;75 years)</li>
                                        <li>Muscle wasting</li>
                                        <li>Electrically inexcitable nerves</li>
                                        <li>Preceding diarrheal illness (C. jejuni)</li>
                                        <li>Need for mechanical ventilation (20% mortality in this group)</li>
                                    </ul>
                                </div>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Follow-up Schedule</h3>
                            <div class="algorithm-path">
                                <h4>Recommended Follow-up Timeline</h4>
                                <ul style="padding-left: 20px;">
                                    <li><strong>Within 2 weeks:</strong> Evaluate for relapse (consider plasma exchange if relapse occurs)</li>
                                    <li><strong>Every 4-6 weeks:</strong> For 6 months (monitor recovery progress)</li>
                                    <li><strong>Every 6 months:</strong> For 1 year</li>
                                    <li><strong>Then annually:</strong> Long-term monitoring</li>
                                </ul>
                            </div>
                        </div>

                        <div class="subsection">
                            <h3>Patient Education & Resources</h3>
                            <div class="highlight-box">
                                <h4>Advice for Patients</h4>
                                <ul style="padding-left: 20px;">
                                    <li>Contact physician immediately for worsening weakness, numbness, breathing/swallowing difficulty, or bladder changes</li>
                                    <li>Continue physiotherapy and occupational therapy</li>
                                    <li>Be aware of possible long-term effects: fatigue, pain, psychological problems</li>
                                    <li>Seek psychological support if needed</li>
                                    <li>Avoid immunizations during acute phase and up to 1 year after onset</li>
                                </ul>
                            </div>
                            <p><strong>Patient Resources:</strong> GBS/CIDP Foundation International (www.gbs-cidp.org)</p>
                        </div>
                    </div>
                </div>
            </div>
        </main>
    </div>

    <button class="scroll-to-top" id="scrollToTop" onclick="scrollToTop()">‚Üë</button>

    <script>
        // Card toggle functionality
        function toggleCard(cardId) {
            const content = document.getElementById(`content-${cardId}`);
            const icon = document.getElementById(`icon-${cardId}`);
            const isExpanded = content.classList.contains('expanded');
            
            // Close all cards
            document.querySelectorAll('.card-content').forEach(card => {
                card.classList.remove('expanded');
            });
            document.querySelectorAll('.expand-icon').forEach(ic => {
                ic.style.transform = 'rotate(0deg)';
            });
            
            // Open clicked card if it wasn't already expanded
            if (!isExpanded) {
                content.classList.add('expanded');
                icon.style.transform = 'rotate(180deg)';
                
                // Smooth scroll to card
                setTimeout(() => {
                    document.getElementById(cardId).scrollIntoView({
                        behavior: 'smooth',
                        block: 'start'
                    });
                }, 100);
            }
        }

        // Progress sidebar functionality
        const progressItems = document.querySelectorAll('.progress-item');
        const cards = document.querySelectorAll('.step-card');

        // Intersection Observer for scroll spy
        const observerOptions = {
            root: null,
            rootMargin: '-20% 0px -60% 0px',
            threshold: 0
        };

        const observer = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    const cardId = entry.target.id;
                    
                    // Update active progress item
                    progressItems.forEach(item => {
                        item.classList.remove('active');
                        if (item.dataset.step === cardId) {
                            item.classList.add('active');
                        }
                    });
                }
            });
        }, observerOptions);

        // Observe all cards
        cards.forEach(card => observer.observe(card));

        // Progress item click handler
        progressItems.forEach(item => {
            item.addEventListener('click', () => {
                const targetId = item.dataset.step;
                const targetCard = document.getElementById(targetId);
                
                // Open the card
                const content = document.getElementById(`content-${targetId}`);
                const icon = document.getElementById(`icon-${targetId}`);
                
                content.classList.add('expanded');
                icon.style.transform = 'rotate(180deg)';
                
                // Scroll to card
                targetCard.scrollIntoView({
                    behavior: 'smooth',
                    block: 'start'
                });
            });
        });

        // Scroll to top button
        const scrollToTopBtn = document.getElementById('scrollToTop');
        
        window.addEventListener('scroll', () => {
            if (window.pageYOffset > 300) {
                scrollToTopBtn.classList.add('show');
            } else {
                scrollToTopBtn.classList.remove('show');
            }
        });

        function scrollToTop() {
            window.scrollTo({
                top: 0,
                behavior: 'smooth'
            });
        }

        // Initialize: Open assessment card by default
        window.addEventListener('load', () => {
            setTimeout(() => {
                document.getElementById('content-assessment').classList.add('expanded');
                document.getElementById('icon-assessment').style.transform = 'rotate(180deg)';
            }, 500);
        });

        // Add fade-in animation on scroll
        const fadeElements = document.querySelectorAll('.fade-in');
        
        const fadeObserver = new IntersectionObserver((entries) => {
            entries.forEach(entry => {
                if (entry.isIntersecting) {
                    entry.target.style.opacity = '1';
                    entry.target.style.transform = 'translateY(0)';
                }
            });
        }, {
            threshold: 0.1
        });

        fadeElements.forEach(element => {
            element.style.opacity = '0';
            element.style.transform = 'translateY(20px)';
            element.style.transition = 'opacity 0.6s ease, transform 0.6s ease';
            fadeObserver.observe(element);
        });

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            const activeCard = document.querySelector('.card-content.expanded');
            if (!activeCard) return;
            
            const currentCard = activeCard.closest('.step-card');
            const allCards = Array.from(document.querySelectorAll('.step-card'));
            const currentIndex = allCards.indexOf(currentCard);
            
            if (e.key === 'ArrowDown' && currentIndex < allCards.length - 1) {
                allCards[currentIndex + 1].querySelector('.card-header').click();
            } else if (e.key === 'ArrowUp' && currentIndex > 0) {
                allCards[currentIndex - 1].querySelector('.card-header').click();
            }
        });

        // Print functionality
        document.addEventListener('keydown', (e) => {
            if (e.ctrlKey && e.key === 'p') {
                e.preventDefault();
                window.print();
            }
        });
    </script>
</body>
</html>